. home.aspx


AI Drug Discovery Consortium Joins Forces with NVIDIA

August 08, 2019 / CRAIG RHODES

Pharmaceutical companies have traditionally kept their data close to the vest because collaborations side effects may include compromising intellectual property and losing the edge over competitors. But sharing data has major perks. The more data a pharma company has at its disposal, the better equipped its researchers are to quickly identify and develop promising new drugs. This can ultimately improve drug candidate success rates and reduce treatment costs.